Detalhe da pesquisa
1.
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
Nat Immunol
; 19(1): 76-84, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29180808
2.
An In Vivo Model of Human Macrophages in Metastatic Melanoma.
J Immunol
; 209(3): 606-620, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817516
3.
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity.
Proc Natl Acad Sci U S A
; 114(49): E10578-E10585, 2017 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158380
4.
Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.
Proc Natl Acad Sci U S A
; 112(7): 2145-50, 2015 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646432
5.
Gene knock-outs in human CD34+ hematopoietic stem and progenitor cells and in the human immune system of mice.
PLoS One
; 18(6): e0287052, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379309
6.
Building the Next Generation of Humanized Hemato-Lymphoid System Mice.
Front Immunol
; 12: 643852, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33692812
7.
Surgical adhesions in mice are derived from mesothelial cells and can be targeted by antibodies against mesothelial markers.
Sci Transl Med
; 10(469)2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30487249
8.
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20.
Cancer Immunol Res
; 4(12): 1072-1087, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856424